Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 17/20 | 0.45 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | CTSB | P07858 | 2/20 | 0.45 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | PRSS8 | Q16651 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6062953 | 0.93 | CTSS (0.43) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL6464673 | 0.81 | PRSS8 (0.40) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL7179322 | 0.79 | CTSS (0.52) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL6061819 | 0.78 | CTSS (0.61) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL7179327 | 0.77 | LMNA (0.38) | CTSSLMNACYP3A4CYP2C9 | |
| SCHEMBL7042145 | 0.76 | CTSS (0.40) | CTSSCTSLCTSBCTSKLMNA | |
| SCHEMBL6062950 | 0.75 | PRSS8 (0.40) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL6062946 | 0.75 | PRSS8 (0.40) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL6468406 | 0.72 | CTSL (0.42) | CTSSCTSLCTSBCTSKPRSS8 | |
| SCHEMBL7048383 | 0.72 | LMNA (0.40) | CTSSLMNAMAPTCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1516877-A1 | Amine derivatives as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-23 | — | — | EP | disclosed |